Structural basis of avian-to-human receptor-binding adaptation in H9Ny influenza A virus hemagglutinin

The receptor-binding specificity of influenza A virus (IAV) hemagglutinin (HA) is a major determinant for viral host tropism, enabling interspecies transmission. The molecular determinants for receptor-binding properties of HAs vary among different IAV subtypes. In this study, we performed a comprehensive analysis on the receptor-binding determinants of IAV subtype H9 HA and found that the receptor-binding characteristics of H9 subtype influenza viruses have exhibited temporal variations over decades. Q226L (hydrophobicity switch) substitution in the 220-loop is the key determinant for H9 subtype HA to acquire human receptor-binding preference. The amino acid residues of the 130-loop greatly affect the binding of HA protein to canonical receptors. Organoid infection models demonstrate that all three representative viral strains could infect human bronchial epithelial organoids. These findings increase our understanding of the molecular determinants of receptor-binding properties of different HA subtypes and call for the surveillance and response to potential influenza outbreaks, or even epidemics/pandemics.IMPORTANCEInfluenza A virus (IAV) subtype H9 poses persistent zoonotic spillover risks due to its adaptive receptor-binding capacity, yet the molecular determinants remain incompletely defined. This study systematically characterizes the receptor-binding determinants of H9 hemagglutinin over decades of viral evolution and identifies two critical functional domains: the 220-loop residue Q226L substitution, which serves as the key mutation conferring human receptor-binding preference, and the 130-loop residues that predominantly modulate canonical receptor-binding affinity. Functional assays using human bronchial epithelial organoids further confirm the robust human infection ability of prevalent H9 viral strains. These findings clarify the molecular mechanisms underlying H9 IAV host tropism and adaptive evolution, provide critical theoretical evidence for targeted influenza surveillance and pandemic preparedness against emerging H9 influenza outbreaks.